STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13D/A] Orthofix Medical Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A
Rhea-AI Filing Summary

Juniper-affiliated investors reported a collective 7.2% beneficial stake in Orthofix Medical Inc. The Schedule 13D/A shows Juniper Targeted Opportunity Fund, Juniper Targeted Opportunities and Juniper Multi-Strategy together hold 2,845,106 common shares, calculated against 39,494,265 outstanding shares as of the July 31, 2025 record date. Juniper Targeted Opportunity Fund purchased 457,680 shares for approximately $6,357,158 between May 9, 2025 and September 25, 2025, and Juniper Multi-Strategy purchased 18,926 shares for approximately $220,256 between May 8, 2025 and June 17, 2025, all in the open market. The filing states no other contracts or arrangements regarding the shares and disclaims broader third-party rights to dividends or proceeds.

Positive
  • Material disclosed stake: Reporting Persons collectively hold 2,845,106 shares (7.2%) of Orthofix based on the July 31, 2025 record date.
  • Open-market purchases disclosed: Juniper Targeted Opportunity Fund acquired 457,680 shares for ~$6.36 million and Juniper Multi-Strategy acquired 18,926 shares for ~$220,256.
  • No special arrangements: The filing states there are no contracts, arrangements, or understandings regarding the securities beyond normal advisory/partner relationships.
Negative
  • None.

Insights

TL;DR: Juniper entities have built a meaningful 7.2% stake through open-market purchases, signaling concentrated investor interest.

The filing documents a collective 2,845,106 share position equal to ~7.2% of Orthofix based on the issuer's July 31, 2025 share count. Purchases were executed in the open market with disclosed aggregate consideration: ~$6.36 million for 457,680 shares by Juniper Targeted Opportunity Fund and ~$220k for 18,926 shares by Juniper Multi-Strategy. For investors, an activist or strategic intent is not explicitly stated; however, filing under Schedule 13D requires disclosure and often precedes engagement. The absence of contracts, arrangements, or special rights suggests the position is currently passive although material in size relative to outstanding float.

TL;DR: The filing discloses beneficial ownership and voting powers but shows no agreements or coordination beyond normal manager relationships.

Reporting persons include investment funds, their general partners, the investment advisor, and two managing members. The filing clarifies sole voting/dispositive power for each fund's holdings and disclaims broader beneficial ownership by affiliated entities and individuals for other purposes. Item 6 states there are no contracts or understandings concerning voting or transfer of the shares. From a governance perspective, this is transparent disclosure of ownership and control lines without current contractual governance commitments.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


Juniper Targeted Opportunity Fund, L.P.
Signature:/s/ John A. Bartholdson
Name/Title:Managing Member of its General Partner, Juniper HF Investors II, LLC
Date:09/25/2025
Juniper HF Investors II, LLC
Signature:/s/ John A. Bartholdson
Name/Title:Managing Member
Date:09/25/2025
Juniper Targeted Opportunities, L.P.
Signature:/s/ John A. Bartholdson
Name/Title:Managing Member of its General Partner, Juniper Targeted Opportunity Investors, LLC
Date:09/25/2025
Juniper Targeted Opportunity Investors, LLC
Signature:/s/ John A. Bartholdson
Name/Title:Managing Member
Date:09/25/2025
Juniper Multi-Strategy Fund, L.P.
Signature:/s/ John A. Bartholdson
Name/Title:Managing Member of its General Partner, Juniper Targeted Opportunity Investors, LLC
Date:09/25/2025
Juniper HF Investors, LLC
Signature:/s/ John A. Bartholdson
Name/Title:Managing Member
Date:09/25/2025
Juniper Investment Company, LLC
Signature:/s/ John A. Bartholdson
Name/Title:Managing Member
Date:09/25/2025
Alexis P. Michas
Signature:/s/ Alexis P. Michas
Name/Title:Managing Member
Date:09/25/2025
John A. Bartholdson
Signature:/s/ John A. Bartholdson
Name/Title:Managing Member
Date:09/25/2025

FAQ

What percentage of Orthofix (OFIX) do Juniper entities now own?

The Reporting Persons collectively beneficially own 2,845,106 shares, representing approximately 7.2% of Orthofix based on 39,494,265 outstanding shares as of July 31, 2025.

How were the shares acquired by Juniper funds?

The disclosed purchases were effected in the open market through a broker; Juniper Targeted Opportunity Fund and Juniper Multi-Strategy made the listed acquisitions.

What were the disclosed purchase amounts and dates?

Juniper Targeted Opportunity Fund purchased 457,680 shares for approximately $6,357,158 between May 9, 2025 and September 25, 2025; Juniper Multi-Strategy purchased 18,926 shares for approximately $220,256 between May 8, 2025 and June 17, 2025.

Do the reporting persons have any special agreements regarding voting or transfer of OFIX shares?

No. Item 6 states there are no contracts, arrangements, understandings or relationships with respect to the Issuer’s securities other than those described in the Schedule 13D/A.

Who are the individuals named in the filing?

The filing names Alexis P. Michas and John A. Bartholdson as managing members of the Juniper entities; both are U.S. citizens and signed the Schedule 13D/A.
Orthofix Med Inc

NASDAQ:OFIX

OFIX Rankings

OFIX Latest News

OFIX Latest SEC Filings

OFIX Stock Data

594.39M
38.64M
2.76%
91.93%
4.6%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
LEWISVILLE